Relay Therapeutics Inc. (RLAY) News

Relay Therapeutics Inc. (RLAY): $22.07

-0.69 (-3.03%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter RLAY News Items

RLAY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

RLAY News Highlights

  • For RLAY, its 30 day story count is now at 9.
  • Over the past 28 days, RLAY's stories per day has been in a clear downtrend, falling by about 0.18 per 3 days.
  • ROSE, LINK and PAY are the most mentioned tickers in articles about RLAY.

Latest RLAY News From Around the Web

Below are the latest news stories about RELAY THERAPEUTICS INC that investors may wish to consider to help them evaluate RLAY as an investment opportunity.

Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks | Oncology Day on Thursday, February 9, 2023 at 10:10 a.m. ET. The fireside chat will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be

Yahoo | February 2, 2023

Relay Therapeutics Inc. (NASDAQ: RLAY): A Great Stock To Watch

Relay Therapeutics Inc. (NASDAQ:RLAY) shares, rose in value on Thursday, 01/19/23, with the stock price down by -2.32% to the previous day’s close as strong demand from buyers drove the stock to $20.20. Actively observing the price movement in the last trading, the stock closed the session at $20.68, falling within a range of $19.49 … Relay Therapeutics Inc. (NASDAQ: RLAY): A Great Stock To Watch Read More »

Stocks Register | January 20, 2023

Relay Therapeutics (RLAY): Tall Claims, Some Proofs Of Concept, Some Concerns

Relay Therapeutics discovers drugs using a novel computational approach. Though I like RLAY stock, see why I will wait for a correction before taking a call.

Seeking Alpha | January 18, 2023

Relay Therapeutics Inc. (NASDAQ: RLAY) Jumps 3.33 Percent In Recent Trading, What Questions Do You Have?

The trading price of Relay Therapeutics Inc. (NASDAQ:RLAY) closed higher on Friday, January 13, closing at $20.77, 3.33% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $19.52 and $21.89. In examining the 52-week price action we see that the stock hit a 52-week … Relay Therapeutics Inc. (NASDAQ: RLAY) Jumps 3.33 Percent In Recent Trading, What Questions Do You Have? Read More »

Stocks Register | January 17, 2023

Relay Therapeutics, Inc. (RLAY) Soars 20.7%: Is Further Upside Left in the Stock?

Relay Therapeutics, Inc. (RLAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | January 13, 2023

Relay Therapeutics Inc. (NASDAQ:RLAY) Could Really Rise To $45.00 In 12 Months, According To Analysts.

In last trading session, Relay Therapeutics Inc. (NASDAQ:RLAY) saw 1.68 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $15.74 trading at $0.23 or 1.48% at ring of the bell on the day assigns it a market valuation of $1.89B. That closing price of RLAY’s stock is … Relay Therapeutics Inc. (NASDAQ:RLAY) Could Really Rise To $45.00 In 12 Months, According To Analysts. Read More »

Marketing Sentinel | January 7, 2023

Can you now get a good deal on Relay Therapeutics Inc.’s shares?

The share price of Relay Therapeutics Inc. (NASDAQ:RLAY) rose to $15.98 per share on Wednesday from $15.04. While Relay Therapeutics Inc. has overperformed by 6.25%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RLAY fell by -50.62%, with highs and lows ranging from $35.36 to $12.65, […]

US Post News | January 5, 2023

Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, is scheduled to present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 2:15 p.m. PT. The presentation will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations . An archived replay of the webcast will be available for up to 30 days following the presentation.

GlobeNewswire | January 3, 2023

Relay Therapeutics, Inc.'s (NASDAQ:RLAY) Intrinsic Value Is Potentially 23% Below Its Share Price

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Relay Therapeutics...

Yahoo | December 31, 2022

Relay Therapeutics Inc. (RLAY) can beat the pack with these strategies

Relay Therapeutics Inc. (NASDAQ:RLAY) marked $14.16 per share on Wednesday, down from a previous closing price of $14.41. While Relay Therapeutics Inc. has underperformed by -1.73%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RLAY fell by -54.56%, with highs and lows ranging from $35.36 to […]

US Post News | December 29, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5508 seconds.